Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

WCCT Global plans strong focus on diabetes clinical trials

US-based contract research organization WCCT Global has announced that it is focusing more on diabetes clinical trials, with rise of the disease.

For several years now, WCCT Global has been developing a patient database and has had a steady flow of possible participants interested in the trials. Following the growing database of diabetic participants, WCCT Global plans to quickly recruit in order to have diabetes studies up and running.

Besides the database, WCCT Global also uses its Recruitment Management Tool (RMT). So far, WCCT Global has been able to identify more than eight million people with diabetes registered to social media accounts. WCCT Global can recruit these patients with the use of the RMT.

WCCT Global Business Development Talia Nikolao said, "With the ever rising number of people who are diagnosed with diabetes, we feel compelled to assist in the development of new treatments to help rid this terrible ailment."

WCCT Global, as a drug development partner, has collaborated with domestic and foreign innovator companies to support them with regulatory program management, data management and strategic consulting support, pediatric populations, ethno-bridging, and cardiac safety.

WCCT Global is a service based contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries.